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Commitment to survival or apoptosis within expanding progenitor populations poses distinct risks and benefits to the organism. We
investigated whether specialized mechanisms regulate apoptosis in mouse neural progenitors and in the progenitor-derived brain tumor
medulloblastoma. Here, we identified constitutive activation of proapoptotic Bax, maintained in check by Bcl-xL, as a mechanism for
rapid cell death, common to postnatal neural progenitors and medulloblastoma. We found that tonic activation of Bax in cerebellar
progenitors, along with sensitivity to DNA damage, was linked to differentiation state. In cerebellar progenitors, active Bax localized to
mitochondria, where it was bound to Bcl-xL. Disruption of Bax:Bcl-xL binding by BH3-mimetic ABT 737 caused rapid apoptosis of
cerebellar progenitors and primary murine medulloblastoma cells. Conditional deletion of Mcl-1, in contrast, did not cause death of
cerebellar progenitors. Our findings identify a mechanism for the sensitivity of brain progenitors to typical anticancer therapies and
reveal that this mechanism persists in medulloblastoma, a malignant brain tumor markedly sensitive to radiation and chemotherapy.
Introduction
Stem cells and progenitor cells are expanding populations that
rigorously calibrate survival decisions. We have recently demon-
strated that embryonic stem (ES) cells regulate apoptosis through
a specialized mechanism in which proapoptotic Bax is constitu-
tively activated and sequestered in the Golgi compartment
(Dumitru et al., 2012). This mechanism eliminates stem cells
with DNA damage. Brain progenitors, like stem cells, have the
potential to propagate mutations caused by genotoxic injury. We
therefore examined whether specialized mechanisms regulate
neural progenitor apoptosis.
Cerebellar granule neuron progenitors (CGNPs) proliferate
rapidly in the postnatal period to give rise to the most numerous
neuronal population in the brain, the cerebellar granule neurons
(CGNs; Miale and Sidman, 1961; Roussel and Hatten, 2011).
Importantly, CGNPs are specifically vulnerable to malignant
transformation, giving rise to medulloblastoma, the most com-
mon malignant brain tumor of children (Grimmer and Weiss,
2006). Apoptosis (Garcia et al., 2013), in concert with p27-
mediated differentiation (Miyazawa et al., 2000; Ayrault et al.,
2009; Bhatia et al., 2010; Parathath et al., 2010), control the
CGNP population growth and suppress tumorigenesis.
CGNPs are markedly prone to apoptosis in response to a va-
riety of stimuli. Exposure of the cerebellum to ionizing radiation
induces CGNP cell death through processes involving Atm, Bax,
and p53 (Chong et al., 2000). Replication stress can also trigger
CGNP apoptosis, as demonstrated by the population-wide death
of CGNPs after deletion of Atr (Lee et al., 2012). CGNP apoptosis
can also be triggered independent of p53, through systemic
administration of glucocorticoid agents (Noguchi et al., 2008;
Heine and Rowitch, 2009).
The vulnerability of CGNPs has important clinical implica-
tions. The sensitivity of CGNPs to DNA damage is recapitulated
in medulloblastoma, which is strikingly responsive to therapies
that cause genotoxic injury. Indeed, 80% of patients are cured
through radiation combined with chemotherapy (Packer et al.,
2006). Conversely, the proapoptotic effect of steroids on CGNPs
can complicate the care of premature infants who are commonly
treated with glucocorticoid agents and are at high risk for im-
paired motor development (Hitzert et al., 2012; ter Wolbeek et
al., 2013). Thus, mechanisms that regulate apoptosis in CGNPs
impact both tumor treatment and brain development.
Bax and Bak are proapoptotic Bcl-2 family proteins that act as
essential triggers of the apoptotic program (Tait and Green,
2010). In most cells, Bax is present in an inactive, monomeric
form that remains in the cytoplasm (Hsu et al., 1997). With the
induction of apoptosis, Bax undergoes a conformational change
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that leads to its oligomerization and translocation to the outer
mitochondrial membrane. Thus activated, Bax induces mito-
chondrial outer membrane permeabilization (MOMP), the first
committed step in the apoptotic process (Wolter et al., 1997;
Antonsson et al., 2001). Importantly, the conformational change
that mediates Bax activation exposes an amino acid motif that is
recognized by monoclonal antibody 6A7, enabling the detection
of Bax activation by immunoprecipitation (IP; Hsu and Youle,
1997). Here, we report that brain progenitors harbor tonically
active Bax at mitochondria, facilitating rapid induction of cell
death in response to diverse proapoptotic stimuli.
Materials and Methods
Generation of mice. The breeding and genotyping of Bax / mice have
been described previously (Knudson et al., 1995). Math-1 cre mice were
generously shared by David Rowitch (University of California, San Fran-
cisco, San Francisco, CA) and Robert Wechsler-Reya (Sanford-Burnham
Medical Research Institute, La Jolla, CA) and have been previously de-
scribed (Matei et al., 2005). hGFAP-cre mice were generously provided
by Eva Anton (University of North Carolina, Chapel Hill, NC); these
mice express cre during brain development in stem cells that give rise to
diverse progeny, including the entire cerebellum (Zhuo et al., 2001).
Mcl-1 f/f mice were generously shared by You-Wen He (Duke University,
Durham NC). SmoM2 mice (strain:5130), p53 / mice (strain:2101),
and Bax f/f; Bak / mice (strain:6329) were obtained from Jackson Lab-
oratories. Medulloblastoma-prone NeuroD2:SmoA1 mice were kindly
provided by James Olson (Fred Hutchinson Cancer Research Center,
Seattle, WA; Hallahan et al., 2004). All mice stated previously were inbred
into the C57 BL/6 background. Wild-type ICR mouse pups were used for
in vivo and CGNP experiments. Genotypes were determined by PCR:
DNA was extracted from toes using Tail Lysis Buffer (Allele, cat#ABP-
PP-MT01). Mice of either sex were used in experiments. All animal han-
dling and protocols were performed in accordance with established
practices as described in the National Institutes of Health Guide for Care
and Use of Laboratory Animals and as approved by the Animal Care and
Use Committee of the University of North Carolina (IACUC# 10-126).
CGNP culture. Primary cultures of CGNPs from ICR mice were gen-
erated according to published protocols (Kenney et al., 2003). When
indicated, CGNPs were maintained continuously in Sonic Hedgehog
(Shh; 0.5 g/ml; R&D Systems). In some experiments CGNGPs contin-
uously maintained in Shh were also treated with 10 M of the Mek inhib-
itor U0126 for 24 h before harvest.
For radiation studies, CGNPs were cultured for 48 h, then subjected to
10Gy using an x-ray irradiator (RS 2000, Rad Source Technologies); cells
were immediately returned to the CO2 incubator and subsequently lysed
after a defined period of time as indicated. Nonradiated cells were har-
vested concurrently with the 4 h samples.
In vivo steroid exposure. For these studies, P7 ICR pups were injected
intraperitoneally with 50 l of Hanks buffered saline, with or without
Dexamethasone (250 M; Sigma, cat#D9184). Cerebella were harvested
after 4 h and processed for Western blot as described below.
In vivo external beam radiation treatment. Mouse pups at P9 or tumor-
bearing pups at P12 were administered continuous anesthesia (Isoflu-
rane, 1.5%) for 4 min inside a small animal research irradiator (RS 2000,
Rad Source Technologies) delivering x-ray irradiation to a total dose of
10Gy. The brain was selectively radiated by shielding the animal with an
elevated lead plate with a 1-cm-wide opening positioned over the poste-
rior fossa. Mice were heated and monitored while recovering from anes-
thesia and returned to a holding cage. Tissue was collected for histology
by drop fixing in 4% formaldehyde for 24 h.
Western blot analysis. Cultured cells, whole cerebella, and tumors were
lysed by homogenization in lysis buffer (Cell Signaling Technology,
cat#9803). Protein concentrations were quantified using the bicin-
choninic acid method (Thermo Scientific, cat#23227) and equal concen-
trations of protein were resolved on SDS–polyacrylamide gels, then
transferred onto PVDF membranes. Immunologic analysis was
performed on a SNAP ID device (Millipore) using manufacturer’s pro-
tocol with primary antibodies to -actin (Cell Signaling Technology,
cat#4970), Bax-N20 (Santa Cruz Biotechnology, sc-493), Bcl-XL (Cell
Signaling Technology, cat#2764), Bad (Cell Signaling Technology,
cat#9239), Bim (Cell Signaling Technology, cat#2933), Puma (Cell Sig-
naling Technology, cat#7467), cleaved caspase-3 (cC3; Cell Signaling
Technology, cat#9664), Cyclin D2 (Cell Signaling Technology, #3741),
Cox4 (Clontech, Cat. No. 630105), and p53 (Cell Signaling Technology,
cat#2524), Mcl-1 (Cell Signaling Technology, cat#5453), Bcl-2 (Cell Sig-
naling Technology, cat#3498), and phospho-ERK1/2 (Cell Signaling
Technology, cat#4370). Secondary antibodies were anti-rabbit IgG HRP
(Cell Signaling Technology, cat#7074) and anti-mouse IgG HRP (Cell
Signaling Technology, cat#7076). Antibody conjugates were visualized
by chemiluminescence (ECL; GE Healthcare, cat#RPN2106).
Immunohistochemistry. For histological analysis and immunohisto-
chemistry (IHC), mouse brain and tumor tissue were embedded in par-
affin and sectioned. H&E-stained sections were prepared using standard
techniques. IHC was performed on paraffin-embedded sections after
deparaffinization in Histoclear and rehydration in a graded ethanol se-
ries, heated to boiling in 10 mM citrate buffer, pH 6.0, in a pressure cooker
for 15 min, then transferred to PBS. After antigen retrieval, IHC was
performed using primary antibodies: proliferating cell nuclear antigen
(PCNA, Cell Signaling Technology, cat#2586), cC3 (Cell Signaling Tech-
nology, cat#9664), and phosphorylated histone H2AX (p-H2AX, Cell
Signaling Technology, cat#9718). Where indicated, nuclei were counter-
stained with 46-diamino-2-phenylindole (DAPI; catalog number
D1306; Life Sciences), diluted 200 ng/ml in PBS for 5 min. Immunoflu-
orescence was evaluated with a Leica epifluorescence DM5000B micro-
scope (Leica Microsystems). Stained slides were then scanned using an
Aperio ScanScope XT.
Immunoprecipitation. For detecting the active form of Bax, tissues or
cells were lysed in CHAPS buffer containing protease inhibitors. IP was
performed by incubating 200 l of a 5 g/l lysate with 40 l of protein
G Sepharose, preabsorbed with 2 g of anti-Bax monoclonal antibody
(clone 6A7, BD-PharMingen) at 4°C for 2 h. After extensive washing with
CHAPS buffer, beads were boiled in 40 l of Laemmli buffer, and 20 l of
the eluted proteins were analyzed by Western blotting. Western blotting
analysis of pre-IP (labeled Input) and immunoprecipitated samples (la-
beled IP) were performed with an anti-Bax polyclonal antibody (Santa
Cruz Biotechnology, Bax N-20, sc-493).
For detecting interaction of Bcl-xL with active Bax or BH3-only pro-
teins, tissues or cells were lysed in CHAPS buffer containing protease
inhibitors. Four micrograms of antibody, either Bax6A7 or Bcl-xL (Cell
Signaling Technology, cat#2764), were cross-linked to Sepharose
beads using disuccinimidyl suberate following the manufacturer’s
instructions (Pierce, Cat#26147). Two-hundred microliters of a 10
g/l lysate were added to the cross-linked antibody beads followed by
incubation by 2 h. After elution of the interaction complexes, Western
blot analysis was performed with Bax (N20), Bcl-XL, Bad, Bim, or Puma
antibodies.
Fractionation. CGNPs in the presence or absence of Shh (as described
previously) were plated into 6-well dishes for 48 h before the experi-
ments. When indicated, CGNPs were then subjected to 10Gy using an
x-ray irradiator and immediately returned to the CO2 incubator for 2 h
before fractionation. The mitochondrial and cytosolic fractions were
prepared using an Apo-Alert cell fractionation kit from BD Biosciences
Clontech. Equal amounts of protein were loaded for Western blot anal-
ysis with Bax and Cox4 or Bcl-xL and Cox4.
BH3 mimetic exposure. An uncoated cell culture plate was equili-
brated at 37°C, CO2 5% with each well containing an adequate vol-
ume of DMEM/F12 (Invitrogen, cat#11330 – 032) supplemented with
1%N2(Life Technologies, cat#17502048), 1%KCl, and 5% fetal bovine
serum at the indicated concentration of ABT 737 (Selleck Chemicals,
cat#S1002) or DMSO. Final DMSO concentration was 1%. Cerebellum
at P6 or P11 or tumor at P12 were quickly dissected and then dissociated
in ice-cold HBSS by repeated trituration with pipette. Cell suspen-
sion was passed through a 40 m cell strainer (Fisher Scientific,
cat#22363547) and centrifuged at 100 rcf for 3 min. Supernatant HBSS
was removed and the cell pellet was resuspended in media and applied in
equal volumes to prepared plate. At 1 h, each well was gently stirred and
total volume of cell suspension was collected and centrifuged at 100 rcf.
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Supernatant media was removed and cell pellet was lysed for protein
analysis.
Results
CGNPs adhere to a rapid, consistent schedule of cell death in
response to genotoxic and nongenotoxic stress
To determine the temporal sequence of apoptosis in CGNPs after
diverse types of injury, we compared the kinetics of cell death
after genotoxic or nongenotoxic stimulus. We provoked apopto-
sis through DNA damage by subjecting P9 mouse pups to 10Gy
external beam radiation treatment (xRT) focused on the poste-
rior fossa. We then analyzed cerebella at progressive intervals
after xRT. We found that radiation induced widespread DNA
damage that was detectable in all neurons and progenitors by
IHC for p-H2AX 1 h later (Fig. 1A). Following a brief, but con-
sistently maintained period of latency, apoptosis began synchro-
nously by 4 h exclusively in the external granule call layer (EGL),
the location of CGNPs, as demonstrated by IHC for cC3 (Fig. 1B).
This precipitous wave of cell death was restricted to a proliferat-
ing subset of CGNPs that populate the outer segment of the EGL
(Fig. 1C).
To induce apoptosis without DNA damage, we subjected P7
mouse pups to corticosteroid injection. Dexamethasone has been
previously reported to induce CGNP cell death 4 h after intra-
peritoneal injection (Noguchi et al., 2008; Heine and Rowitch,
2009). We confirmed that CGNP death proceeded 4 h after stim-
ulus and demonstrated that apoptosis proceeded without induc-
tion of p-H2AX (Fig. 1D). Thus, CGNPs demonstrated a rapid
apoptotic response with a consistent temporal onset after differ-
ent types of injury.
The timing of cell death after injury was also recapitulated
with remarkable fidelity in primary murine medulloblastoma. To
examine the kinetics of cell death in medulloblastoma, we bred
Math1-cre (Matei et al., 2005) and SmoM2(Mao et al., 2006)
mouse lines. In the resulting Math1-cre:SmoM2 pups, a consti-
tutively active allele of Smoothened (SmoM2) is induced through
cre-mediated recombination in the Math1-lineage, which in the
cerebellum is restricted to the CGNPs and CGNs. These mice
synchronously develop medulloblastoma with 100% incidence
(Mao et al., 2006; Schüller et al., 2008), detectable by P12 as a
characteristic expansion of the occipital region. Histologic anal-
ysis demonstrated replacement of the entire EGL with growing
tumor in which scattered cells undergo spontaneous apoptosis
(Fig. 2A, inset). We subjected tumor-bearing mice at P12 to 10Gy
xRT and then monitored the induction of DNA damage and cell
death. We found that in tumors, as in the EGL, DNA damage was
already detectable 1 h after treatment, while cell death increased
precipitously by 4 h (Fig. 2B,C). Thus, in vivo CGNPs and me-
dulloblastoma cells adhered to a rapid, consistent schedule of cell
death after injury.
Bax is the principal death effector in CGNPs and is not
complemented by Bak
To identify the molecular mechanism of rapid CGNP death, we
compared the response to xRT of CGNPs deficient in Bax, Bak, or
both Bax and Bak. We bred and then radiated P9 mouse pups
with genotypes Bax/;Bak/ (Bax het), Bax/;Bak/ (Bak
KO), Bax/;Bak/ (Bax KO), and hGFAP-cre;Bax fl/fl;Bak/
(double KO). We found that Bax deletion greatly reduced CGNPs
apoptosis after xRT, while Bak deletion had minimal effect, and
codeletion of Bax and Bak completely blocked xRT-induced cell
death (Fig. 3A–D). Importantly, these findings demonstrate that
neural progenitor death after xRT is apoptotic in nature, and does
not result from any property of dividing cells unrelated to the
apoptotic machinery. Moreover, these findings demonstrate that
Figure 1. CGNPs adhere to a consistent schedule of rapid apoptosis after injury. A, Radiation, administered as 10 Gy xRT focused on the posterior fossa, induced DNA damage in CGNPs of the EGL
and CGNs of the IGL that was detectable by IHC for pH2AX at both 1 and 4 h. B, Apoptosis, demonstrated by cC3, was undetectable during the latent period after xRT (1 h), then began precipitously
by 4 h. C, Immunofluorescence for cC3 (green) and PCNA (red) demonstrates that apoptosis was confined to the proliferative layer of the EGL. D, Corticosteroids induced apoptosis (cC3) without
genotoxic injury (pH2AX). Scale bars: A, B, 250 m; A, B (insets) 100 m; C, D, 50 m.
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Bax is the principal effector of CGNP
death, and that Bak does not effectively
compensate for Bax in these cells.
Mitogenic signaling maintains active
Bax at mitochondria without apoptosis
To understand how Bax drives the rapid,
rigorously maintained pattern of CGNP
death 4 h after proapoptotic stimulus, we
examined the temporal sequence of Bax
activation. We used IP with antibody 6A7
to detect Bax in the active conformation
in lysates of whole cerebella or of iso-
lated CGNPs, cultured in the presence or
absence of Shh. Shh is the endogenous mi-
togen for CGNPs, and serum-free media
supplemented with Shh maintains freshly
isolated CGNPs in a proliferative state; cul-
tured without Shh, CGNPs survive but stop
dividing and differentiate (Wechsler-Reya
and Scott, 1999; Kenney and Rowitch,
2000).
We were surprised to find that in the
absence of proapoptotic stimulus, CGNPs
maintain Bax in an active conformation.
Importantly, activated Bax was markedly
reduced when CGNPs differentiated to
CGNs. Using immunoprecipitation, we de-
tected active Bax in lysates of whole cerebella
specifically during the period of CGNP pro-
liferation (Fig. 4A). Smoothened-induced
medulloblastomas, in both ND2:SmoA1
(Hallahan et al., 2004) and Math1-cre;
SmoM2 mice, similarly demonstrated active
Bax. Importantly, by isolating CGNPs, and
adding or withholding Shh from cultures,
we were able to determine that CGNPs
maintain Bax in active conformation only
when stimulated to proliferate (Fig. 4B).
Subcellular fractionation of cultured
CGNPs, moreover, demonstrated increased
mitochondrial localization of Bax by
CGNPs maintained in Shh (Fig. 4C). The
conformational change and mitochondrial
localization of Bax were not accompanied
by increased apoptosis (Fig. 4D).
While the presence of active Bax in
CGNPs did not cause spontaneous apopto-
sis, we noted that Shh-treated CGNPs were
differentially sensitive to genotoxic stimu-
lus. We pooled freshly harvested CGNPs,
divided them into Shh- or vehicle-
supplemented wells and subjected all wells
to 10 Gy radiation, then harvested cultures
for Western blot at progressively greater
intervals. Shh-treated CGNPs initiated apo-
ptosis by 3 h after irradiation, while vehicle-
treated CGNPs demonstrated minimal
increase in cell death (Fig. 4E). Thus, prolif-
erating CGNPs harbored active Bax, and
while not committed to apoptosis, were
primed to initiate rapid cell death after DNA
damage.
Figure 2. Medulloblastoma, like CGNPs, undergoes rapid apoptosis after genotoxic injury. A, IHC for cC3 demonstrates basal
level of apoptosis typical of medulloblastoma in Math1-cre;SmoM2 mice. B, 10 Gy xRT caused DNA damage throughout the tumor
and adjacent cerebellum, which was detectable by IHC for pH2AX at 1 and 4 h after treatment. C, As in CGNPs, apoptosis was
undetectable during the latent period after xRT (1 h), then began precipitously in the tumor cells by 4 h. Scale bars: A–C, 500 m;
A (inset), 50 m.
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Preactivated Bax in CGNPs is sufficient to cause apoptosis
To test whether the abundance of active Bax in CGNPs was suf-
ficient to cause cell death, we examined the dynamics of Bax
conformation changes elicited by proapoptotic stimulus. We in-
duced CGNP apoptosis in vivo with systemic dexamethasone,
and we analyzed the abundance of Bax detectable by 6A7 IP be-
fore or after treatment. While dexamethasone induced apoptosis
in CGNPs 4 h after an IP dose as expected (Fig. 4F, input lysates),
we detected equivalent active Bax in dexamethasone-injected and
sham-injected mice (Fig. 4F, 6A7 IP). These data show that
CGNPs harbor potentially lethal levels of active Bax, and can
trigger cell death without additional Bax conformation change.
Activation of Bax in CGNPs is increased by p53 and decreased
by p44/42 MAPK
Because of the correlation between proliferation and Bax activa-
tion we investigated the role of replication stress and canonical
mitogenic signaling in controlling Bax conformation in CGNPs.
Previous investigations have documented that disruption of
DNA repair in CGNPs causes p53-dependent cell death (Orii et
al., 2006), suggesting an endogenous tendency to suffer DNA
damage during replication. We therefore tested whether p53 reg-
ulated the proportion of Bax that was activated in CGNPs. We
found that active Bax was detectable, but markedly less abundant,
in cerebellum lysates from pups with genetic deletion of p53
(p53/) compared with cerebellum lysates from p53/ litter-
mates (Fig. 5A). Importantly, we found that Shh-maintained
CGNPs increased expression of the BH3-only protein Puma (Fig.
5B), a mechanism previously noted to coordinate the activation
of p53 and Bax in vitro (Chipuk et al., 2005). Thus, although p53
was not strictly required for tonic Bax activation, the proportion
of active Bax was augmented through a p53-dependent mecha-
nism, potentially mediated by Puma, that did not require exoge-
nous proapoptotic stimulation.
While p53 positively regulated Bax activation, we found that
the mitogen-activated protein kinase (MAPK) signaling activity
correlated inversely with activation of Bax. To investigate the role
of MAPK signaling in regulating Bax, we exposed Shh-treated
CGNPs in vitro to the Mek inhibitor U0126. Mek activates Erk1
and Erk2 (p44/p42 MAPK) through phosphorylation. We found
that U0126 markedly reduced phosphorylated p44 and p42 in
CGNPs (Fig. 5C). Blocking Mek-Erk signaling did not inhibit
Figure 3. Vulnerability of CGNPs to apoptosis is not a direct consequence of cell cycling but rather depends specifically on Bax. A, Proliferating CGNPs in a Bax heterozygous mouse underwent
precipitous apoptosis 4 h after xRT, as expected. B, Genetic deletion of Bak did not markedly alter the pattern of xRT-induced apoptosis. C, In contrast, genetic deletion of Bax dramatically reduced
xRT-induced apoptosis, despite the presence of intact Bak. D, Conditional deletion of Bax in CGNPs, combined with genetic deletion of Bak, completely blocked the apoptotic effect of xRT. Scale bars,
100 m.
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CGNP proliferation, as demonstrated by persistent, slightly in-
creased expression of CGNP proliferation marker Cyclin D2.
When replicate wells were subjected to 6A7 IP, we found that
compared with vehicle, Shh increased the proportion of Bax in
active conformation, and this proportion was further increased
by U0126 (Fig. 5C). Apoptosis followed the pattern of Bax acti-
vation as cC3 increased with U0126 treatment (Fig. 5C). Thus,
p44/p42 MAPK inhibition in Shh-treated CGNPs produced an
additive effect on Bax activation, indicating that p44/p42 MAPK
negatively regulates Bax activation in CGNPs.
Active Bax in CGNPs is bound to Bcl-xL
The presence of active Bax in viable CGNPs implies a mechanism
to prevent initiation of apoptosis. The antiapoptotic Bcl2 family
protein Bcl-xL has been previously demonstrated to bind to ac-
tive Bax, allowing mitochondrial translocation without MOMP
(Llambi et al., 2011). We examined the possibility that active Bax
was present at mitochondria and bound to Bcl-xL or its ho-
mologs Bcl-2 and Mcl-1, by comparing lysates of whole cerebella
either during peak CGNP proliferation (P7) or after CGNPs had
completed differentiation (adult). We subjected lysates from P7
or adult cerebella to IP with Bax antibody 6A7, then detected
Bcl-2, Bcl-xL, and Mcl-1 by Western blot. While all three anti-
apoptotic proteins were detectable in cerebellum lysates (Fig. 6A,
inputs lanes), only Bcl-xL coprecipitated with active Bax, and
only at P7 (Fig. 6A, 6A7 IP lanes). Thus, active Bax interacted
specifically with Bcl-xL, specifically during the period of CGNP
proliferation. Consistent with these data, IP for Bcl-xL followed
by Western blot for Bax confirmed the Bax:Bcl-xL interaction
during postnatal cerebellar neurogenesis (Fig. 6B). Together,
these findings demonstrate that active Bax associates specifically
with Bcl-xL in proliferating CGNPs.
To exclude the possibility that Bcl2 homologs other than
Bcl-xL regulate Bax in CGNPs, we examined whether deleting
Mcl-1 in these cells causes apoptosis. Previous investigations have
shown that in contrast to Bcl-2, which is not required during
brain development (Veis et al., 1993; Nakayama et al., 1994; Ka-
mada et al., 1995), Mcl-1 is required for the survival of primitive
neuro-glial stem cells that are targeted by Nestin-cre (Arbour et
al., 2008). Our finding that Mcl-1 did not immunoprecipitate
with active Bax in CGNPs, however, suggested that Mcl-1 might
not regulate the survival of these less pluripotent, neural progen-
itors. We assayed the dependence of CGNPs on Mcl-1 by testing
the effect of conditional Mcl-1 deletion. We bred Mcl-1 floxed
Figure 4. Proliferating CGNPs harbor active Bax in lethal abundance, enabling rapid commitment to cell death. A, Representative IP using Bax 6A7 antibody on lysates of whole cerebellum or
Smo-induced medulloblastoma demonstrate tonic activation of Bax during cerebellar neurogenesis and tumor growth. B, Isolated CGNPs harbor Bax in an active conformation only when maintained
in Shh-containing media. C, Western blot for Bax after subcellular fractionation demonstrates increased Bax at mitochondria of CGNPs cultured in Shh, compared with CGNPs deprived of Shh (V).
Western blot for Cox4 demonstrates effectiveness of mitochondrial enrichment. D, Western blots on the input lysates used in B: despite increased Bax activation, Shh-treated CGNPs did not
demonstrate increased cC3. Increased Cyclin D2 in Shh-treated CGNPs confirms that Shh effectively maintained a proliferative state in vitro. E, Isolated CGNPs maintained in Shh underwent
radiation-induced apoptosis after a consistent latent period. CGNPs maintained in vehicle without Shh (V) did not undergo apoptosis after xRT. F, Dex induced apoptosis in CGNPs that was detectable
by Western blot for cC3 in whole cerebellum lysates 4 h after intraperitoneal injection, without causing an increase in active Bax, as detected by 6A7 IP.
Figure 5. Bax activation is positively regulated by p53 and negatively regulated by p44/p42
MAPK. A, Genetic deletion of one or both copies of p53 caused a dose-dependent reduction in
the proportion of active Bax, along with a reduction in the abundance of p53 protein. Even in the
absence of p53, however, active Bax remained detectable by 6A7 IP. B, Western blot demon-
strates increased Puma in isolated CGNPs maintained in Shh. C, Western blot from CGNPs main-
tained in vitro demonstrates effective inhibition of p44/p42 MAPK phosphorylation by Mek
inhibitor U0126. Mek inhibition did not block Shh-induced proliferation, as demonstrated by
CGNP proliferation marker Cyclin D2. Mek inhibition produced an additive increase in Bax acti-
vation, demonstrated by 6A7 IP (middle panel of right column) that exceeded the effect of Shh
alone.
Crowther, Gama et al. • Tonic Bax Activation in Neural Progenitors J. Neurosci., November 13, 2013 • 33(46):18098 –18108 • 18103
mice (Dzhagalov et al., 2007) with Math1-cre mice, to delete
Mcl-1 in committed neural progenitors including the CGNP
population (Machold and Fishell, 2005; Wang et al., 2005). West-
ern blot analysis of whole cerebellum at P7 demonstrated de-
creased Mcl-1 protein, but no significant increase in cleavage of
caspase-3 (Fig. 6C). Histologic analysis demonstrated no defects
in the layers of CGNPs that form the EGL and no increase in
cC3 CGNPs (Fig. 6D). Thus, disrupting Mcl-1 in CGNPs was
not sufficient to induce cell death. Together, our data support a
model in which CGNPs and medulloblastoma cells modulate
commitment to cell death by maintaining Bax in an active state,
and by strictly modulating the tendency of active Bax to trigger
apoptosis via interaction specifically with antiapoptotic Bcl-xL.
Bad, Puma, and Bim are BH3-only proteins that have been
reported to antagonize the antiapoptotic effect of Bcl-xL in di-
verse cells (Yang et al., 1995; Willis et al., 2005; Chipuk and
Green, 2009; Follis et al., 2013; Kodama et al., 2013). To identify
proteins that act on Bcl-xL at the initiation of apoptosis in
CGNPs, we compared the expression of Bad, Puma, and Bim, and
the interaction of these proteins with Bcl-xL, before and shortly
after apoptotic stimulation. We harvested whole cerebella at P7,
during the peak of CGNP proliferation, and compared them to
P7 cerebella of mice that were exposed to 10Gy xRT focused on
the posterior fossa. Radiated mice were harvested 2 h after treat-
ment to obtain CGNPs after proapoptotic stimulus but before
caspase-3 cleavage and DNA fragmentation. Harvested cerebella
were lysed and analyzed by Western blot to compare untreated
samples to radiated samples. We found that Bad and Puma both
increased in abundance with xRT. Only Bad, however, coprecipi-
tated with Bcl-xL, and this interaction increased markedly with
xRT (Fig. 6E). In contrast to this increase in Bcl-xL:Bad interac-
tion with initiation of cell death, we did not find a change in
Figure 6. Bcl-xL interacts with active Bax in nonapoptotic CGNPs, and with Bad after induction of apoptosis, while genetic deletion excludes Mcl-1 as a key modulator of CGNP survival. A,
Representative Western blots for Mcl-1, Bcl2, Bcl-xL, and Bax using lysates of whole cerebellum from P7 or adult mice, before and after IP with Bax 6A7 antibody. Of the antiapoptotic Bcl2 family
protein tested, only Bcl-xL interacted with active Bax during cerebellar neurogenesis. B, Representative Western blot for Bax, reciprocal to A, before and after IP using Bcl-xL antibodies, confirms the
temporal pattern of Bax:Bcl-xL interaction. C, Western blot demonstrates reduced Mcl-1 protein in whole cerebellum lysates of Math1-cre;Mcl-1 f/f mice compared with littermate controls, with no
detectable increase in cC3. D, Representative sections of cerebellum from littermates with indicated genotype, stained with H&E (top) or by IHC for cC3 (bottom). Boxes in top panels demonstrate
the regions magnified in the bottom, where the EGL is identified. No increase in apoptosis was found in CGNPs with Mcl-1 deletion. Scale bars: 200 m (top); 50 m (bottom). E, Representative
Western blots for Bad, PUMA, and BIM, before and after IP with Bcl-xL antibody. Whole cerebella from P7 mice are compared, either with no proapoptotic stimulus or 2 h after 10 Gy of radiation. xRT
induced binding of Bcl-xL to Bad during this latent period before radiation-induced apoptosis begins. F, Western blot for Bcl-xL or mitochondrial marker Cox4 after subcellular fractionation. Two
hours after xRT, no redistribution of Bcl-xL from mitochondria to cytoplasm was observed.
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Bcl-xL localization. We performed subcellular fractionation on
isolated CGNPs, either without radiation or 2 h after 10Gy xRT.
We than analyzed cytosolic and mitochondrial fractions by West-
ern blot for Bcl-xL and Cox4. We found Bcl-xL, like Cox4, pre-
dominantly in the mitochondrial fraction both before and after
xRT (Fig. 6F). Thus, Bcl-xL did not translocate out of mitochon-
dria with provocation of apoptosis. These data suggest that
CGNP apoptosis is triggered at the mitochondria, where in-
creased Bcl-xL:Bad interaction releases activated Bax.
BH3-mimetic agent ABT 737 rapidly induces Bax-driven
apoptosis in CGNPs and medulloblastoma in the absence of
genotoxic injury
To determine the functional significance of the interaction be-
tween active Bax and Bcl-xL in CGNPs, we used the BH3 mimetic
agent ABT 737 to disrupt Bax:Bcl-xL binding (Oltersdorf et al.,
2005; Kang and Reynolds, 2009; Vogler et al., 2009). Because
ABT37 does not penetrate the blood– brain barrier, we developed
the technique of exposing freshly harvested, dissociated cerebel-
lum or tumor to ABT 737 in vitro, then measuring apoptosis by
Western blot for cC3. Remarkably, after only 1 h of exposure to
ABT 737, both CGNPs and medulloblastoma cells underwent
apoptosis precipitously, in a dose-dependent manner (Fig. 7A).
This unexpectedly rapid induction of cell death contrasted with
the induction of cell death after xRT or corticosteroid exposure,
which consistently followed a latent period. Sensitivity to ABT
737 depended on the differentiation state of CGNPs, as ABT 737
did not induce death in dissociated cells from adult cerebella (Fig.
7B). Importantly, the proapoptotic effect of ABT 737 was abro-
gated in CGNPs and medulloblastomas from Bax-deficient mice
(Fig. 7C). Thus, the rapid induction of death triggered in these
cells by ABT 737 was specifically Bax dependent and develop-
mentally regulated.
Discussion
In this investigation we have demonstrated that primary neural
progenitors, like embryonic stem cells, are configured for rapid,
Bax-dependent cell death. While a variety of stimuli were able to
initiate CGNP apoptosis, the timing of death remained constant,
beginning synchronously after a consistent latent period of 1 h
and 4 h. The capacity for CGNPs to undergo cell death was tied
to their proliferation state: differentiating CGNPs of the inner
EGL did not initiate apoptosis after xRT, and Shh-deprived
CGNPs in culture were similarly radiation resistant. Importantly,
we found that the developmental mitogen Shh maintained not
only the proliferation of CGNPs but also the presence of active
Bax within these cells. Like proliferating CGNPs, cells of primary
mouse medulloblastoma harbored active Bax and were prone to
synchronous apoptosis at a defined interval after xRT. Moreover,
we found that survival of CGNPs and medulloblastoma cells re-
quired the interaction of active Bax with Bcl-xL. Thus, CGNPs are
configured for rapid cell death by the presence of preactivated
Bax, held in check at mitochondria, and this mechanism remains
engaged after malignant transformation to medulloblastoma.
Like human ES cells, CGNPs maintain a capacity for rapid
initiation of apoptosis by harboring active Bax. However, CGNPs
responded to ABT 737 with extremely rapid induction of apopto-
sis, while we previously found that ABT 737 did not induce death
in human ES cells (Dumitru et al., 2012). This differential sensi-
tivity highlights key differences in the regulation of Bax in ES cells
and CGNPs. While ES cells sequester Bax in the Golgi, CGNPs
maintain active Bax at mitochondria where it triggers MOMP
when released from the inhibitory effect of Bcl-xL. This mecha-
nism renders CGNPs acutely dependent on the antiapoptotic
effect of Bcl-xL and thus rapidly vulnerable to ABT 737. Impor-
tantly, our finding that DNA damage induced the BH3-only pro-
tein Bad to bind Bcl-xL suggests that Bad is the endogenous
trigger for MOMP that is bypassed by ABT 737. Thus, although
tonic activation of Bax is a common feature of ES cells and
CGNPs, each cell type has a specific mechanism of maintaining
its closely regulated survival.
The ability of CGNPs to survive deletion of Mcl-1 further
demonstrates that survival mechanisms are cell-type specific even
within the limited subset of brain precursors. In previous inves-
tigations, conditional deletion of Mcl-1 with FoxG1-cre or
Nestin-cre caused embryonic lethality, with widespread apopto-
sis in the telencephalon at E12.5, and thus demonstrated that
survival of early telencephalic neuro-glial precursors requires
Mcl-1 (Arbour et al., 2008). In contrast, we found that mice in
which Mcl-1 was conditionally deleted in unipotent neural pro-
genitors with Math1-cre were viable and without overt neuro-
logic deficits. Mcl-1-deficient CGNPs did not demonstrate
increased apoptosis and generated a normal appearing EGL.
Thus, although CGNPs were so dependent on antiapoptotic pro-
teins that ABT 737 provoked Bax-dependent death within 1 h,
these cells survived Mcl-1 deletion. Our findings demonstrate
Figure 7. BH3-mimetic agent ABT 737 induces rapid, Bax-dependent apoptosis of prolifer-
ating CGNPs and medulloblastoma cells. A, ABT 737 induced highly rapid apoptosis of dissoci-
ated cerebellar progenitors and medulloblastoma cells 1 h after exposure, in a dose-dependent
manner, as demonstrated by Western blot for cC3. B, Adult cerebellum, which contains all
cerebellar cell types except CGNPs, did not demonstrate apoptosis after 1 h of exposure to ABT
737. P11 cerebellum, which contains CGNPs, demonstrated robust, dose-dependent apoptosis.
C, The induction of apoptosis in CGNPs and medulloblastoma cells by ABT 737 was markedly
reduced by genetic deletion of Bax.
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that the vulnerability of postnatal neural progenitors is not a
consequence of their rapid proliferation, but rather the outcome
of a highly specific molecular process of survival regulation.
The mechanism of Bax activation in CGNPs remains to be
elucidated. Previous investigations have demonstrated that Bax
can be activated either by BH3-only proteins, including Puma
(Letai et al., 2002; Melino et al., 2004; Kuwana et al., 2005) or
directly by p53 (Chipuk et al., 2004). Our finding that Bax acti-
vation was positively regulated by p53 is consistent with both
possibilities. Puma was initially identified as a BH3-only protein
upregulated by p53 (Nakano and Vousden, 2001). We found that
Puma was upregulated by DNA damage induced by xRT and also
by Shh. It is possible that Shh-induced proliferation causes en-
dogenous genotoxic injury through replication stress, and that
this stress induces p53-mediated upregulation of Puma. Thus,
Puma may link proliferation to activation of Bax. Nevertheless,
additional activators of Bax must function in CGNPs as p53 de-
letion reduced Bax activation in CGNPs but did not eliminate it.
The presence of redundant systems of Bax activation would also
be consistent with the observation that p53 deletion does not
prevent corticosteroid-induced CGNP apoptosis (Noguchi et al.,
2008).
Conversely, we found that p44/p42 MAPK signaling nega-
tively regulated Bax activation in proliferating Shh-treated
CGNPs. Inhibiting this pathway through Mek inhibition in-
creased the proportion of activated Bax and promoted apoptosis.
Importantly, the link between proliferation and Bax activation
was not altered by Mek inhibition, as Shh-induced proliferation
did not decrease. Our data are consistent with previous studies
that demonstrated that p44/p42 MAPK is not required for Shh-
induced proliferation (Kenney and Rowitch, 2000). Our data are
also consistent with previous studies that demonstrated an anti-
apoptotic effect of p44/p42 MAPK in cerebellar granule neurons
differentiated from CGNPs in vitro by Shh withdrawal (Bonni et
al., 1999). Together, these findings demonstrate a role for p44/
p42 MAPK signaling in maintaining the survival of both CGNPs
and their differentiated progeny.
Previous investigators have delineated models of apoptosis
regulation in which viable cells maintain Bax and Bak alternately
in an inactive conformation, or in a constitutively active confor-
mation but suppressed by antiapoptotic proteins (Letai et al.,
2002; Green, 2006). The latter model in which antiapoptotic pro-
teins are required to prevent active Bax from inducing MOMP
has been described as addiction to antiapoptotic proteins that
leaves cells “primed for death.” The primed-for-death state has
previously been attributed to growth factor withdrawal, physio-
logic stress, or malignant growth (Certo et al., 2006). Impor-
tantly, in CGNPs we have identified a cell type that is primed for
death in the course of unperturbed development in vivo. In these
progenitors, the addiction to antiapoptotic proteins, demon-
strated by ABT 737 sensitivity, is not a consequence of exogenous
stress but rather a developmentally regulated phenotype. This
developmental primed-for-death state seems well suited to the
specific context of postnatal neurogenesis, in which individual
cells are replaceable and preventing the propagation of mutations
is paramount. In this context, the remarkable sensitivity of me-
dulloblastoma to cytotoxic therapy may be understood as inher-
ited from the premalignant cells of origin.
Importantly, the sensitivity of neural progenitors to DNA-
damaging therapies has emerged as a clinically significant prob-
lem that may contribute to the lingering encephalopathy after
cancer treatment, commonly referred to as “chemobrain”
(Christie et al., 2012; Monje and Dietrich, 2012). While we inves-
tigated Bax regulation in CGNPs, neural progenitors of the hip-
pocampus and subventricular zone may be similarly calibrated to
undergo rapid cell death through tonic Bax activation. The ther-
apy that effectively treats medulloblastoma also causes long-term
cognitive decline (Ris et al., 2013). Our data suggest a common
mechanism links the sensitivity of brain progenitors and
medulloblastoma.
We found that medulloblastoma maintained the tonic activa-
tion of Bax that was typical of proliferating CGNPs. A malignant
tumor of neural progenitors, medulloblastoma has long been
known to be markedly more sensitive to cytotoxic therapy than
other malignant brain tumors. We have previously found that
spontaneous apoptosis is an active process active in both mouse
medulloblastoma and in medulloblastomas resected from pa-
tients. The possibility that tumor cells in human medulloblas-
toma are primed for death is supported by the manifest sensitivity
of medulloblastoma to DNA-damaging therapy (Packer et al.,
2006; Packer and Vezina, 2008) and by our previous observation
that the rate of apoptosis varies inversely with the expression of
antiapoptotic Bcl-2 (Garcia et al., 2013). Our current findings
that CGNPs and medulloblastoma cells maintain Bax in active
conformation suggests a potential mechanism for the known sen-
sitivity of medulloblastoma to therapies that act through DNA
damage and relate this sensitivity to the developmental cell of
origin. The strong vulnerability of medulloblastoma to the Bcl-
2/Bcl-xL inhibitor ABT 737 in our model, moreover, suggests
that targeting specific antiapoptotic Bcl-2 family proteins may be
a new avenue for medulloblastoma therapy.
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